Taipei Veterans General Hospital

:::

李沛璋 (Pei-Chang Lee)

Appointment

[Profile]

Education
Career and Experience
Current Positions：
- - Now, Attending Physician, Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
- - Now, Assistant Professor, National Yang-Ming Chiao-Tung University School of Medicine, Taipei, Taiwan,
Experiences：
- - , Chief Resident, Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
- - , Resident, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
Medical Expertise
1. 1. Liver cirrhosis and its complications
2. 2. Abdominal ultrasound and GI tract endoscopy
3. 3. Nutrition therapy
4. 4. Endoscopic Retrograde Cholangiopancreaticography, biliary stent implacement, GI tract stent placement
License

Board-certified Physician, Diploma of Department of Health, Executive Yuan, Taiwan Board-certified Gastroenterologist and Instructor, Diploma of The Gastroenterological Society of Taiwan Board-certified Digestive Endoscopist and Instructor, Diploma of The Digestive Endoscopy Society of Taiwan

[Publications]

1. Lee PC, Wu CJ, Hung YW, Lee CJ, Chi CT, Lee IC, Kuo YL, Chou SH, Luo JC, Hou MC, Huang YH. Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma. J Immunother Cancer. 2022 Jun; 10(6):e004779.
2. Lee PC, Hsieh YC, Huo TI, Yang UC, Lin CH, Li CP, Huang YH, Hou MC, Lin HC, Lee KC. Active Vitamin D3 Treatment Attenuated Bacterial Translocation via Improving Intestinal Barriers in Cirrhotic Rats. Mol Nutr Food Res. 2021 Feb;65(3):e2000937.
3. Lee PC, Chang TE, Wang YP, Lee KC, Lin YT, Chiou JJ, Huang CW, Yang UC, Li FY, Huang HC, Wu CY, Huang YH, Hou MC. Alteration of gut microbial composition associated with the therapeutic efficacy of fecal microbiota transplantation in Clostridium difficile infection. J Formos Med Assoc. 2021 Nov 23;S0929-6646(21)00498-8.
4. Lee PC, Chao Y, Chen MH, Lan KH, Lee IC, Hou MC, Huang YH. Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma. J Immunother Cancer. 2020 Aug;8(2):e001072.
5. Lee PC, Chao Y, Chen MH, Lan KH, Lee CJ, Lee IC, Chen SC, Hou MC, Huang YH. Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma. Cancers (Basel). 2020 Jan 11;12(1).